TOP TIERMARKET NEWSWIRE
News & sentiment

CARTESIAN THERAPEUTI Equity (RNAC) — News & AI sentiment

CARTESIAN THERAPEUTI Equity (RNAC) news roundup. 1 story in the last 24 hours, 3 in the past week, 3 over 30 days. Average 24-hour sentiment is 52/100 — neutral (50 is neutral). No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
1
avg sentiment 52/100
7d stories
3
avg sentiment 56/100
30d stories
3
avg sentiment 56/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

RNAC news in the last 24 hours, 7 days, 30 days and 90 days

How much RNAC coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowRNAC storiesAvg AI sentimentRead
Last 24 hours152/100RNAC headlines →
Last 7 days356/100RNAC headlines →
Last 30 days356/100RNAC headlines →
Last 90 days1555.9/100RNAC headlines →

Latest stories on RNAC

1d ago
1d ago
6d ago
Oct 2
Oct 2
H.C. Wainwright reiterates Cartesian Therapeutics stock rating at buy
Investing.com Analyst Ratings61 · neutralanalyst
Sep 30
Sep 29
Sep 29
Sep 29
Sep 29
Sep 8
Sep 8
Sep 3
Sep 3
Aug 7
Cartesian Therapeutics EPS of $0.46
Seeking Alpha34 · bearishearnings
Aug 6
Aug 6
Aug 6
Jul 2
Jun 17
Jun 12
Jun 9
Jun 9
Jun 9
Jun 9
Open RNAC in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →